Journal Articles OncoImmunology Year : 2016

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

Dates and versions

hal-02461588 , version 1 (30-01-2020)

Identifiers

Cite

Heng Yang, Yuting Ma, Guo Chen, Heng Zhou, Takahiro Yamazaki, et al.. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. OncoImmunology, 2016, 5 (6), pp.e1149673. ⟨10.1080/2162402X.2016.1149673⟩. ⟨hal-02461588⟩
260 View
0 Download

Altmetric

Share

  • More